Northwestern Memorial Researchers Aim To Find Answer To Halting The Progression Of Fatty Liver

... Currently, no medical treatment exists for nonalcoholic steatohepatitis (NASH), inflammation of the liver associated with the accumulation of fat in the liver. NASH can result in scarring of the liver in up to 40 percent of people with the disease and cirrhosis in approximately 25 percent of people with NASH. Researchers at Northwestern Memorial Hospital have launched a clinical trial to see if Pentoxifylline can stop the progression of NASH. ...